BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naito T. Emerging Treatment Options For Cancer-Associated Cachexia: A Literature Review. Ther Clin Risk Manag 2019;15:1253-66. [PMID: 31754304 DOI: 10.2147/TCRM.S196802] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Matsuo H, Sakuma K. Pathophysiology of Cachexia and Characteristics of Dysphagia in Chronic Diseases. Asia-Pacific Journal of Oncology Nursing 2022. [DOI: 10.1016/j.apjon.2022.100120] [Reference Citation Analysis]
2 Motoo Y, Cameron S. Kampo medicines for supportive care of patients with cancer: A brief review. Integrative Medicine Research 2022;11:100839. [DOI: 10.1016/j.imr.2022.100839] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
3 Gumpper-Fedus K, Hart PA, Belury MA, Crowe O, Cole RM, Pita Grisanti V, Badi N, Liva S, Hinton A, Coss C, Ramsey ML, Noonan A, Conwell DL, Cruz-Monserrate Z. Altered Plasma Fatty Acid Abundance Is Associated with Cachexia in Treatment-Naïve Pancreatic Cancer. Cells 2022;11:910. [PMID: 35269531 DOI: 10.3390/cells11050910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Yehia R, Schaalan M, Abdallah DM, Saad AS, Sarhan N, Saleh S. Impact of TNF-α Gene Polymorphisms on Pancreatic and Non-Small Cell Lung Cancer-Induced Cachexia in Adult Egyptian Patients: A Focus on Pathogenic Trajectories. Front Oncol 2021;11:783231. [PMID: 34900737 DOI: 10.3389/fonc.2021.783231] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Naito T. Nursing Management of Cancer Cachexia: A New Frontier. Asia Pac J Oncol Nurs 2021;8:442-4. [PMID: 34527773 DOI: 10.4103/apjon.apjon-2133] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Zhao Y, Pang D, Lu Y. The Role of Nurse in the Multidisciplinary Management of Cancer Cachexia. Asia Pac J Oncol Nurs 2021;8:487-97. [PMID: 34527778 DOI: 10.4103/apjon.apjon-2123] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Trestini I, Sperduti I, Sposito M, Kadrija D, Drudi A, Avancini A, Tregnago D, Carbognin L, Bovo C, Santo A, Lanza M, D'Onofrio M, Tortora G, Bria E, Milella M, Pilotto S. Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome. ESMO Open 2020;5:e000689. [PMID: 32424067 DOI: 10.1136/esmoopen-2020-000689] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
8 Zheng H, Pan Q, Zhu W, Li H, Niu Z, Fang Y, Li D, Lou H, Hu H, Shou J, Pan H. Novel Nutrition-Based Nomograms to Assess the Outcomes of Lung Cancer Patients Treated With Anlotinib or Apatinib. Front Oncol 2021;11:628693. [PMID: 33763364 DOI: 10.3389/fonc.2021.628693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Straughn AR, Kelm NQ, Kakar SS. Withaferin A and Ovarian Cancer Antagonistically Regulate Skeletal Muscle Mass. Front Cell Dev Biol 2021;9:636498. [PMID: 33718372 DOI: 10.3389/fcell.2021.636498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chen M, Li S, Topatana W, Lv X, Cao J, Hu J, Lin J, Juengpanich S, Shen J, Cai X. Development and Validation of a Nomogram for Predicting Survival in Gallbladder Cancer Patients With Recurrence After Surgery. Front Oncol 2020;10:537789. [PMID: 33505902 DOI: 10.3389/fonc.2020.537789] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 T de Barros C, Rios AC, Alves TFR, Batain F, Crescencio KMM, Lopes LJ, Zielińska A, Severino P, G Mazzola P, Souto EB, Chaud MV. Cachexia: Pathophysiology and Ghrelin Liposomes for Nose-to-Brain Delivery. Int J Mol Sci 2020;21:E5974. [PMID: 32825177 DOI: 10.3390/ijms21175974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Farhang-Sardroodi S, Wilkie KP. Mathematical Model of Muscle Wasting in Cancer Cachexia. J Clin Med 2020;9:E2029. [PMID: 32605273 DOI: 10.3390/jcm9072029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Kang JS. Dietary restriction of amino acids for Cancer therapy. Nutr Metab (Lond) 2020;17:20. [PMID: 32190097 DOI: 10.1186/s12986-020-00439-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
14 Miyawaki T, Naito T, Kodama A, Nishioka N, Miyawaki E, Mamesaya N, Kawamura T, Kobayashi H, Omori S, Wakuda K, Ono A, Kenmotsu H, Murakami H, Notsu A, Mori K, Harada H, Endo M, Takahashi K, Takahashi T. Desensitizing Effect of Cancer Cachexia on Immune Checkpoint Inhibitors in Patients With Advanced NSCLC. JTO Clin Res Rep 2020;1:100020. [PMID: 34589927 DOI: 10.1016/j.jtocrr.2020.100020] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]